1. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings;Mirowski, M.; Reid, P.R.; Mower, M.M.; Watkins, L.; Gott, V.L.; Schauble, J.F.;N EnglJ Med,1980
2. Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death;Reid, P.R.; Mirowski, M.; Mower, M.M.; Platia, E.V.; Griffith, L.S.; Watkins, L.;Am Jf Cardiol,1983
3. Efficacy of the automatic implantable cardioverterdefibrillator in prolonging survival in patients with severe underlying cardiac disease;Fogoros, R.N.; Elson, J.J.; Bonnet, C.A.; Fiedler, S.B.; Burkholder, J.A.;J Am Coll Cardiol,1990
4. ACC/AHA Task Force report: guidelines for implantation of cardiac pacemakers and antiarrhythmic devices;Dreifus, L.S.; Fisch, C.; Griffin, J.C.; Gillette, P.C.; Mason, J.W.; Parsonnet, V.;J7 Am Coll Cardiol,1991
5. Task Force of the Working Group on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Guidelines for the use of implantable cardioverter defibrillators,1992